ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014

Recombinant TSH Avoids Need To Stop Replacement Therapy

January 27, 2006

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort

November 24, 1995

In Brief: Senate Markup Of Cancer Act Renewal Bill Delayed Again; New Money Levels Considered Still Too Low

November 9, 1979

In Brief: Search Committee Finds Prospects Uncertain About Election, Unwilling To Take Pay Cut

February 22, 1980